U.S. wants COVID vaccine patent waiver to benefit world, not boost China biotech – Reuters

  1. U.S. wants COVID vaccine patent waiver to benefit world, not boost China biotech  Reuters
  2. U.S. Support for Patent Waiver Unlikely to Cost Covid-19 Vaccine Makers in Short Term  The Wall Street Journal
  3. With a Covid-19 vaccine patent waiver likely, time to rethink global intellectual property rules  CNN
  4. Drug companies dig in for global patent fight amid flow of billions in vaccine revenue  The Washington Post
  5. Waiver of patent rights on Covid vaccines may be mostly symbolic, for now  STAT
  6. View Full Coverage on Google News